Oxytocin: a hormone with an approval for labour and a research literature about everything else
An approved obstetric drug, a research tool in hundreds of psychology studies, and a wellness product. The gap between those three is wider than almost anything else in this reference, and the replication problem is the interesting part.
- Also known as
- OT, bonding hormone, Pitocin (Rx)
- Class
- Supplement
- Regulatory status
- FDA approved as Pitocin for labor induction. Off-label intranasal use for wellness. Compounding pharmacies produce intranasal formulations.
- Before mixing
- Sealed powder tolerates room temperature in transit, but keep it refrigerated at 2–8 °C (36–46 °F) for anything beyond a few weeks, or frozen for months. Keep it dark — the carton it shipped in is doing a job.
- After mixing
- Once reconstituted with bacteriostatic water: refrigerate at 2–8 °C and use within about 28 days. The benzyl alcohol in bacteriostatic water is what buys that window — plain sterile water has no preservative, so a vial mixed with it should be treated as one sitting only. Kits are usually ten vials: only the one you mixed is on that 28-day clock — the sealed ones keep their own, much longer shelf life, so store them as powder, not as solution.
- What ruins it
- Do not freeze a reconstituted vial. Repeated freeze–thaw is one of the more reliable ways to degrade a peptide.
- Handling caveat
- General handling practice for this formulation. Your supplier’s own insert or COA overrides anything here.
What is established, and what the nose has to do with it
Established clinical use Oxytocin is a nine-amino-acid peptide made in the hypothalamus. Its approved use is intravenous, for labour induction and postpartum haemorrhage, and that pharmacology is not in question. What is in question is everything downstream of the claim that spraying it up the nose produces central effects.
The problem is delivery. Oxytocin is a peptide, cleared from blood in minutes, and it does not meaningfully cross the blood-brain barrier. The intranasal route is proposed to bypass that via the olfactory and trigeminal pathways, and there is evidence that some reaches cerebrospinal fluid — but the fraction is small, the dose-response is not established, and how much of any observed effect comes from central versus peripheral action is genuinely unresolved.
Animal-only or theoretical That matters because the intranasal literature is enormous and its replication record is poor. Early findings on trust, generosity and social cognition were striking and have replicated inconsistently; the field is now a standard example in discussions of underpowered studies and publication bias. This is not a compound with little evidence — it is a compound with a great deal of evidence pointing in several directions.
The effect people actually report
Off-label or community practice Setting the research aside, the reported subjective effects are consistent: a short window of warmth, social ease and heightened emotional responsiveness, sometimes with an effect on arousal, lasting under an hour. The app’s dosing rows describe as-needed use before an event, which follows from a half-life measured in minutes.
The app’s drawbacks list contains one item worth taking seriously: it is emotionally sensitising rather than uniformly positive. The same amplification that makes a good interaction better makes a difficult one worse, and the research on this is more consistent than the research on the benefits — effects appear to depend heavily on context and on the person. Anyone expecting a reliable mood lift is expecting the wrong thing.
Tolerance is the other reported constraint, and it is why the app frames this as intermittent rather than daily. Receptor downregulation under repeated stimulation is plausible for any peptide hormone and is not specifically demonstrated here.
Practical points
The approved product is intravenous and for a completely different purpose. Intranasal preparations are compounded, so concentration and sterility rest with the compounder, and this site names no pharmacy. Nothing on a routine panel tracks it; the app records mood self-assessment and cortisol only where stress is a separate concern, which is honest.
The muscle and recovery claims in circulation come from animal work on satellite cell activation and are a long way from a human outcome. Treating them as established is the kind of extrapolation this site keeps flagging.
Anyone taking psychiatric medication, or using this to manage a mood or relationship difficulty, should be having that conversation with a clinician rather than a page — a compound that amplifies emotional response is not a neutral addition to either situation.
The dosing rows the app records
Established clinical use Reproduced from the app’s reference so you can see what it holds, not as a recommendation. Which row applies to a particular person, if any, is a clinical decision this page does not make — and rows describing supraphysiological or post-cycle use are filtered out before this table is built, so what you see here is a subset.
| Label | Amount | Route and frequency | Duration recorded |
|---|---|---|---|
| Intranasal | 8-24 IU (2-6 sprays) | Intranasal — 1 spray per nostril, 2-3x weekly | As needed — avoid daily use |
| Subcutaneous | 5-10 IU | Subcutaneous injection — as needed | As needed — avoid frequent daily use |
What the app monitors alongside it
The panel below is the app’s own monitoring note for Oxytocin, verbatim. None of the analytes it names has a page here yet.
- Monitoring panel
- Mood self-assessment, cortisol (if stress is a concern), libido and social wellness tracking. No specific blood monitoring required.
Drawbacks and risks the app records
From the app’s own entry, and the last item is the most useful thing on it: this amplifies whatever is there rather than reliably improving it.
- Intranasal route required for CNS effects — not effective orally
- Very short half-life — effects last 30-60 minutes
- Tolerance develops with frequent use — limit to a few times weekly
- Can cause headache at higher doses
- Not FDA approved for performance or recovery use
- Emotionally sensitizing — can intensify negative as well as positive emotions
Questions people actually ask
Does intranasal oxytocin reach the brain?
Some appears to, via olfactory and trigeminal routes, and the fraction is small and the dose-response is not established. How much of any observed effect is central rather than peripheral remains unresolved.
Why is the research so inconsistent?
Because much of it was underpowered and the early striking findings have replicated poorly. It is now a standard case study in discussions of replication in psychology, which is a reason to read confident claims about it carefully.
How long does it last?
Under an hour, subjectively. The peptide itself is cleared in minutes, which is why the app’s rows describe taking it shortly before something rather than on a schedule.
Does it help recovery or muscle?
The claims come from animal work on satellite cell activation. No human outcome supports it, and treating that as established is a long extrapolation.
Where the load-bearing numbers come from
Named rather than linked. Publisher URLs move, and a citation that resolves to a 404 two years from now is worse than one you can search for by name — every entry below is findable from the title and year alone.
- Approved intravenous indication
- The approval string in the fact box is app.html’s own field, reproduced verbatim
- Intranasal delivery to the central nervous system
- Evidence that a small fraction reaches cerebrospinal fluid; dose-response is not established
- Replication record of the social-cognition literature
- Widely documented; early findings have replicated inconsistently in larger studies
- Context dependence of effects
- Reported more consistently than benefit itself across the intranasal literature
An as-needed compound with a context-dependent effect is one where your own notes are the only evidence. TherapyLog keeps them with the dose.
Save this dose to your log